Stephens & Co. : The DermTech (DMTK.US) rating was reaffirmed and adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, with a target price of $1.50.
Zhitong FinanceApr 19 22:40
Stephens & Co. Reiterates Equal-Weight on DermTech, Maintains $1.5 Price Target
BenzingaApr 19 22:36
DermTech Analyst Ratings
BenzingaApr 19 18:34
DermTech (DMTK) Was Downgraded to a Hold Rating at BTIG
TipRanksApr 19 18:16
BTIG Remains a Buy on DermTech (DMTK)
TipRanksMar 11 18:30
DermTech Analyst Ratings
BenzingaMar 8 00:42
DermTech Analyst Ratings
BenzingaMar 5 22:09
Stephens & Co. Maintains Equal-Weight on DermTech, Lowers Price Target to $1.5
BenzingaMar 5 22:11
DermTech (DMTK) Receives a Buy From Lake Street
TipRanksMar 1 21:55
Craig-Hallum Releases a Buy Rating on DermTech (DMTK)
TipRanksFeb 26 22:07
Analysts' Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)
TipRanksFeb 1 21:50
Craig-Hallum Remains a Buy on DermTech (DMTK)
TipRanksJan 9 22:09
DermTech (DMTK) Gets a Buy From BTIG
TipRanksJan 7 18:28
BTIG Analyst Reiterates Buy Rating for DermTech: Revenue Growth, Strategic Expansion and Promising TRUST-II Study
TipRanksNov 6, 2023 07:58
DermTech (DMTK) Receives a Buy From Lake Street
TipRanksNov 3, 2023 20:56
Craig-Hallum Remains a Buy on DermTech (DMTK)
TipRanksNov 1, 2023 21:21
DermTech Analyst Ratings
BenzingaAug 7, 2023 23:00
Lake Street Remains a Buy on DermTech (DMTK)
TipRanksAug 4, 2023 21:15
DermTech (DMTK) Gets a Buy From Craig-Hallum
TipRanksJul 31, 2023 20:36
Analysts Offer Insights on Healthcare Companies: DermTech (DMTK) and NeuroPace (NPCE)
TipRanksJun 29, 2023 21:40
No Data
No Data